Skip to main content
. 2020 Jul 18;20:675. doi: 10.1186/s12885-020-07179-4

Table 3.

HER2 classification changes in the NAT and no-NAT group from paired biopsy and surgical specimens

Surgery
Biopsy
Negative Ambiguous Positive p value No. cases with loss of HER2 No. cases with gain of HER2
No-NAT group (N = 61) Negative 40 5 2 0.4165 2 8
Ambiguous 1 3 1
Positive 0 1 8
NAT group (N = 78) Negative 55 4 1 0.6616 4 5
Ambiguous 2 5 0
Positive 2 0 8
Unkown 0 1 0

NAT Neoadjuvant therapy